Back
Monopar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
MNPR
Monopar Therapeutics
Last Price:
$40.10
Seasonality Move:
-15.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.86 | Buy |
| 20-day SMA: | 35.76 | Buy |
| 50-day SMA: | 36.04 | Buy |
| 200-day SMA: | 29.46 | Buy |
| 8-day EMA: | 31.07 | Buy |
| 20-day EMA: | 17.92 | Buy |
| 50-day EMA: | 8.46 | Buy |
| 200-day EMA: | 2.31 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.51 | Buy |
| Relative Strength Index (14 RSI): | 56.12 | Buy |
| Chaikin Money Flow: | -81115 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 38.25) | Buy |
| Bollinger Bands (100): | (31.78 - 40.22) | Buy |
Monopar Therapeutics Technical Analysis
| Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.76 while MNPR 8-day simple moving average is 38.86, which is a Buy signal.
-
The stock price of MNPR is 39.76 while Monopar Therapeutics 20-day SMA is 35.76, which makes it a Buy.
-
Monopar Therapeutics 50-day simple moving average is 36.04 while MNPR share price is 39.76, making it a Buy technically.
-
MNPR stock price is 39.76 and Monopar Therapeutics 200-day simple moving average is 29.46, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $39.76. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
243.1M
Price in USD:
39.76
Share Volume:
85.6K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 39.76 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 39.76 while MNPR 8-day exponential moving average is 31.07, which is a Buy signal.
-
The stock price of MNPR is 39.76 while Monopar Therapeutics 20-day EMA is 17.92, which makes it a Buy.
-
Monopar Therapeutics 50-day exponential moving average is 8.46 while MNPR share price is 39.76, making it a Buy technically.
-
MNPR stock price is 39.76 and Monopar Therapeutics 200-day simple moving average is 2.31, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.66 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is 10.51, suggesting Monopar Therapeutics is a Buy
-
Monopar Therapeutics Relative Strength Index (RSI) is 56.12, which suggest Monopar Therapeutics is overbought
-
The Bollinger Bands (25) for Monopar Therapeutics is (32.65 - 38.25), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (31.78 - 40.22), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.